Announcements Trials
Browse Landscape

Phase

Phase 3 14Phase 2 11Phase 4 10Phase NA 9Phase 2/3 7Phase EARLY_PHASE1 5Phase 1/2 4Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pain 1Neoplasms 1Head and Neck Neoplasms 1Depressive Disorder, Major 1Chronic Pain 1Cancer Pain 1Acute Pain 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Ketamine × Clear all
NCT05156060 2024-10-21

Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Phase 1/2 Recruiting
64 enrolled
Head & Neck

Head and Neck Neoplasms

NCT04471818 2023-09-28

KODIAC

Instituto Nacional de Cancerologia de Mexico

Phase 1/2 Completed
19 enrolled

Depressive Disorder, Major

NCT03146806 2021-09-09

Intranasal (NAS) Ketamine for Cancer Pain

Emory University

Phase 1/2 Completed
10 enrolled 26 charts

Cancer Pain, Neoplasms, Pain

NCT02462681 2017-07-02

Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery

Assiut University

Phase 1/2 Completed
90 enrolled

Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡